COMPANY RESEARCH
Molecule Group plc
MOL.L · United Kingdom · Healthcare · Pharmaceutical Retailers
INSIDER SIGNAL
Insider activity score：50.5 / 100
1 insiders · 1 purchase events · €46k net purchases
Europe #628 · United Kingdom #160
WHY THIS SIGNAL?
Score anatomy
Each bar shows the contribution to the current score; the weights and formula stay unchanged.
Cluster+10.5 / 35
How many distinct insiders bought in the cluster
Purchase size+17.4 / 25
Purchase value relative to company size and liquidity
Role+15.0 / 20
The seniority and relevance of participating insiders
Recency+7.6 / 10
How recently the purchases occurred
Conviction+10.0 / 10
How clearly buying stands out from other activity
What is holding the score back?
- ⚠ Buyer breadth is moderate · fewer than 4 distinct filers
- ✓ Strong insider role · c-suite involved
- ✓ Recent activity · latest purchase 2026-10-13
The role contribution uses the inverted role input of the current European model.
Buying concentration
100%
Largest buyer：Brendan O’Brien · 39k GBP
Gross qualified purchase transaction-line value：39k GBP
The headline € total is net buying for the screen; this module uses gross qualified purchase transaction-line values in the filing currency, so the amounts can differ. The current 15-day buyer-breadth input counts distinct buyers; value concentration is disclosed separately here.
This is a ranking under the current European screening rules—not a probability of gain, return forecast, or buy recommendation.
Key purchase quotes (filing currency)
| Filer | Price per unit | Trade date |
|---|---|---|
| Brendan O’Brien | 2.14 GBP | Oct 13, 2026 |
Model details
Cluster breakdown (does not change the score)
- 15-day buyer breadth (count)
- 1 distinct reported filers
- Peak time window
- 2026-10-13 to 2026-10-13
- Current breadth input
- 0.300 (capped at 4+ buyers)
- Buyer independence
- Not yet measured; related-party fields are not cross-market comparable
What the filings show
- 🟢 Recent eligible purchase
Brendan O’Brien · 39k GBP · Price 2.14 GBP · Oct 13, 2026
Insider vs stock price
1 purchase day(s), 1 purchase line(s) in the 180-day window.
Daily close (GBp)Day with an insider purchase
Markers sit on the closing price of the transaction day. They show when insiders traded, not the price they paid or received. "Since" compares that day's close with the last close shown; it is what happened at this company, not a forecast.
If you had followed the purchase
Each row starts on the first close on or after the day a purchase was made public, the earliest a reader could have acted, and ends on the last close shown above.
| Made public | Insiders | In this stock, now | In the median peer stock, now | Difference |
|---|---|---|---|---|
| 2026-10-13 | 1 | 1,000 +0.0% | 1,000 +0.0% | 0 +0.0 pts |
0 of 1 disclosure day(s) ended ahead of the median peer stock.
Close to close, before costs, taxes, dividends and currency moves. The peer is the median of the other stocks on the same exchange for which this site holds prices (113 here), not an index. This is what happened, not a forecast: across all purchases on this site the typical gap is close to zero.
Insider timeline
One insider bought, once (13 Oct). The share closed at 206.00 that day and at 206.00 most recently (+0.0%).
Tap an item for what it means.
●A purchase: the bigger the dot, the more was bought
Each dot is one insider's purchases on one day. The dot's area follows the amount: the largest purchase here gets the largest dot. Hold the pointer over a dot to see the date and the amount.
Blue line: this share's price, −10.4% over these six months
The closing price of each day, from 230.00 on 2026-04-21 to 206.00 on 2026-10-15. The line has no scale; read it for high and low: a dot on a low stretch was bought cheaply, a dot on a high stretch was not.
Dashed line: the typical stock on the same exchange, +2.6%
Taken from the 491 other stocks on the same exchange that this site holds prices for. Each is measured from the first day of the window, and every day the middle one is drawn. It starts where the blue line starts, so the gap between the two is the difference: this share −10.4%, the typical one +2.6%, 13.0 points behind. It is not an index and not a comparison within one industry.
▂Grey bars: companies across Europe disclosing purchases each week
A taller bar is a week in which more companies disclosed insider purchases.
This company: insiders buying per month, last 12 months
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
1Oct
Darker bars are inside the 180-day window above.
Who traded
| Insider | Role | Purchases | Sales | Bought | First purchase | Share price since | Earlier purchases |
|---|---|---|---|---|---|---|---|
| Brendan O’Brien | Executive | 1 | — | 39.2k GBP | 2026-10-13 | +0.0% | fewer than 5 completed |
Why this score? · Model details
Priority = 100 × Σ(fixed weight × 0–1 rule-based input)
| Factor | Weight | This company input | Point contribution |
|---|---|---|---|
| 15-day buyer breadth (count) | 35% | 0.300 | 10.5 |
| Qualified-buy size | 25% | 0.697 | 17.4 |
| Role informativeness (inverted) | 20% | 0.250 | 5.0 |
| Recency | 10% | 0.758 | 7.6 |
| Buy/sell conviction | 10% | 1.000 | 10.0 |
This is a heuristic ordering under the current rules, not a calibrated return forecast. It explains why candidates rank differently; the public-filing evidence and data limits are shown below.
BULL VS BEAR
Two readings of this buying
The same filings, read two ways. Each line is a fact stored for this company with the number behind it, and appears only when that number crosses a fixed threshold. Neither side is a forecast and no winner is declared.
Since 2026-10-13: new on the bear side: loss-making, thinly traded. All bull and bear lists, and what followed each line in the past →
Where the evidence comes from
The two kinds of evidence disagree: the purchases themselves carry bull lines (senior executive buying, bought in the last two weeks), while company results argue against (loss-making).
- The insider purchases themselvesBullsenior executive buying, bought in the last two weeks Bearone buyer only5 checked, under the threshold · 3 missing
- Share price and tradingBearthinly traded2 checked, under the threshold
- Short sellers1 checked, under the threshold
- Company resultsBearloss-making1 missing
- Company actions1 checked, under the threshold
Bull case · the buying is informative
- The buyers include a senior executive, who sees more of the business than most filers. This site's score gives little or no credit for that: in its backtests purchases by senior executives did no better than other insiders' purchases.Record: after 8,797 earlier disclosures like this, the median 60-session excess return was −3.1%, within 1 percentage point of all comparable disclosures (−3.2%).
- The latest purchase is 4 days old (2026-10-13). The buying is current, not left over from an earlier quarter.
Bear case · discount it
- Only one insider bought. A single purchase can reflect that person's own finances rather than a view on the company.Record: after 4,732 earlier disclosures like this, the median 60-session excess return was −2.7%, within 1 percentage point of all comparable disclosures (−3.3%).
- Company resultsThe company is loss-making on the latest captured figures: profit margin −53%, return on equity −24%.
- Share price and tradingAbout €48k of the stock changes hands on an average day, below this site's €500k screening line. A position is hard to enter or leave at the quoted price.
Evidence still missing
- No buyer here has 5 or more completed earlier purchases on record, so there is no track record to weigh.
- Only one reading of profitability is held (profit margin −53%). Whether earnings and cash flow are rising or falling needs the last two reports side by side.
- European notifications have no field saying whether a purchase was pre-arranged; there is no counterpart to the US 10b5-1 box. The one purchase line does not mention a plan, but a bare “Acquisition of Ordinary Shares” does not rule one out.
- The filings give the size of each trade, not what the buyer already held. Whether a purchase added 1% to a personal stake or doubled it is not known.
Checked and under the threshold: 9, 2 close to it
- EitherInsider purchases in the last 20 sessions equal 4.9% of the stock's traded value. Bull from 5.0%, bear below 0.50%. close to the threshold
- BearOver three months the share price changed −22% and the median of 271 Healthcare companies changed −6.3%: behind by 15 points. Counted for the bear side from 20 points behind. close to the threshold
- Either1 insider bought in the last 180 days and 0 in the 180 days before. Bull when the number at least doubles and rises by two; bear when at least two bought before and no more buy now.
- Bear0 of 1 buyer filed as a person closely associated with a manager. Counted for the bear side from half.
- EitherNet purchases equal 0.07% of the company's market value. Bull from 0.10%, bear below 0.01%.
- BearNo insider sale is recorded in the same 180 days.
- BearThe share price changed −5.9% over six months (three months −22%, one month +2.5%) and stands 27% below its 52-week high. Counted for the bear side from a fall of 20%.
- BearThe register of FCA shows no published net short position in this company.
- BullThe company announced no transaction in its own shares in the last 30 days.
Both columns arrange stored facts only. They do not change the insider score or the ranking and are not investment advice.
Signal history
50.5 / 100
Latest recorded score
↓ -2.4 ptssince the first recorded snapshot on 2026-10-13; 5 calendar days observed
- Recorded snapshots
- 5
- First snapshot
- 2026-10-13
There is not yet a 30-calendar-day comparison; earlier scores are not reconstructed. These are raw signal scores saved when each full scoring run completed. They describe changes in research ranking, not price performance or returns.
Why did it change?
Less than 30 days of comparable history is available, so factor movement is not yet decomposed.
Signal score history
Fixed 0–100 scale; dates are spaced by calendar time.
Recent recorded points
- 52.9
- 52.2
- 51.6
- 51.0
- 50.5
View all recorded scores
| Snapshot date | Signal score |
|---|---|
| 2026-10-13 | 52.9 |
| 2026-10-14 | 52.2 |
| 2026-10-15 | 51.6 |
| 2026-10-16 | 51.0 |
| 2026-10-18 | 50.5 |
Sector context
- Buying breadth
- 6.1% (48 / 792 issuers)
- Sector rank
- #11 / 12
- 7D breadth change
- -0.4 pp · vs 2026-10-12 (6d)
- 30D breadth change
- History building
This is sector-level research context. It does not affect the Insider Signal or ranking.
Insider profile outcomes
Historical performance following insider filings. The company role is translated below each name while preserving the original title.
- Excess return = stock return − FTSE 100 return over the same period.
- Hit rate = completed events with positive excess return ÷ total completed events.
- Price coverage = valid point-in-time prices ÷ events mature enough for that period.
- Returns start on the first shared trading session on or after publication.
- Small-sample rule: n<5 is shown for transparency and is not scored.
Events are disclosure-level observations; related disclosures published on the same date may share a return path and may not be statistically independent. This research enrichment does not affect the insider score or ranking.
Market context
PRICE PERFORMANCE
VOLATILITY & LIQUIDITY
- Volatility
- 13189.9%
- Beta
- —
- Avg daily volume
- £95,600.5
VALUATION
- Market cap
- £56.2M
- P/E
- —
FUNDAMENTALS
- Profit margin
- -53.3%
- ROE
- -24.3%
- Industry
- Pharmaceutical Retailers
Prices to 15 Oct 2026: OpenBB/yfinance; volume from price cache (yfinance). From OpenBB/yfinance, captured 18 Oct 2026: Market cap, Profit margin, ROE, Industry. It does not affect the insider score or rank.
Disclosed net short positions
The FCA register, read 18 Oct 2026, publishes no aggregate net short position for this issuer.
Short-position disclosures are external context; they do not affect the insider score, ranking, or filing eligibility.
Insiders' buying price vs the latest close
Insiders paid 2.14 GBP a share on average (1 purchase line, 1 buyer, 2026-10-13 – 2026-10-13). The close on 2026-10-15 was 3.7% below that price.
Prices paid are weighted by shares and taken from the filings; dividends are not counted. Not scored.
Buying size vs market trading
4.85% · of estimated traded value in the same period
2026-09-18 – 2026-10-15 · 20 recorded trading sessions
- Disclosed qualifying purchases
- 39,162 GBP
- Estimated market traded value
- 807,222 GBP
Market-data coverage: 284 verified sessions · Latest session: 2026-10-15 · Ratio status: Available
Recent and largest purchase events / preceding 60-session ADTV
- Oct 13 · Brendan O’Brien · Chief Operating Officer39,162 GBP · 36.98%105,911 GBP ADTV
Traded value is estimated as close × shares traded, in major currency units. Includes disclosed qualifying purchases; disclosures may lag. Contractual or planned acquisitions are not necessarily discretionary. Ratios describe relative trading size, not market participation or score contributions.
Latest news
No news has been captured for this company.
Regulatory filings
- Insider filing announcement · published 2026-10-13 · trade date 2026-10-13
Filing evidence
These are underlying national-feed records from the 365-day window ending on the saved ranking snapshot. The score uses only the latest 180 days; older qualifying equity purchases remain visible for audit but do not enter the current score. The original filer, role, transaction classification, instrument, price, volume, value and source fields are retained. The first three rows are shown; remaining records can be unfolded for audit. Other transaction types are retained but excluded from the score.
Excluded transactions & classification
1 qualifying purchase disclosure(s) · 1 transaction line(s)
Oct 13, 2026Acquisition of Ordinary Shares
Brendan O’Brien · Chief Operating Officer
Ordinary Shares of 10 pence each · 18300 shares × 2.14 GBP · —
Open filingShowing 1 of 1 matching raw-feed row(s) from the current 365-day research window. Prices and reported values remain in the filing currency and its major unit (for example, UK pence are parsed as GBP). The screen-level € aggregate is separately FX-normalised for research ranking, not a trade-date conversion.
Other disclosed transactions · excluded from score
The underlying filing feed is unavailable in this snapshot; this is not a claim that no filings exist.
Snapshot & identity
- Snapshot date
- 2026-10-18
- Ticker
- MOL.L
- ISIN
- GB00BTQLZH16
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
Company logos by Parqet